Literature DB >> 15845757

Effects of previous major depressive illness on cognition in Alzheimer disease patients.

H Eleanor Cannon-Spoor1, James A Levy, George S Zubenko, Wendy W Zubenko, Robert M Cohen, Nadeem Mirza, Karen Putnam, Trey Sunderland.   

Abstract

OBJECTIVE: Major Depressive Disorder (MDD) may be a risk factor for subsequent development of irreversible dementia; however, the influence of a premorbid history of MDD on the clinical course of patients diagnosed with probable Alzheimer disease (AD) has not been fully explored.
METHODS: Forty-three AD patients with mild-to-moderate cognitive impairment were screened for a life-long history of MDD with the Clinical Assessment of Depression in Dementia Scale. Twenty-two subjects had a history of MDD before onset of cognitive impairment, but none was suffering from an MDD episode at time of cognitive assessment.
RESULTS: After controlling for age, education, duration of illness, gender, and medication status, subjects with a history of MDD had significantly lower scores, as a group, on cognitive performance tests, including the Mini-Mental State Exam, WAIS Full-Scale and Verbal Scale I.Q., and the Initiation/Perseveration subscale of the Mattis Dementia Rating Scale. These subjects also developed symptoms of dementia at a significantly earlier age than the subjects who had no premorbid history of MDD.
CONCLUSIONS: Although previous studies have shown that late-onset MDD may increase risk for subsequent dementia, the current results suggest that premorbid MDD is associated with more severe cognitive deficits during the actual course of dementia.

Entities:  

Mesh:

Year:  2005        PMID: 15845757     DOI: 10.1176/appi.ajgp.13.4.312

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  7 in total

Review 1.  Mood, cognition and in vivo protein imaging: the emerging nexus in clinical neuroscience.

Authors:  Anand Kumar; Olusola Ajilore; Vladimir Kepe; Jorge R Barrio; Gary Small
Journal:  Int J Geriatr Psychiatry       Date:  2008-06       Impact factor: 3.485

Review 2.  Management of psychiatric and neurological comorbidities in epilepsy.

Authors:  Andres M Kanner
Journal:  Nat Rev Neurol       Date:  2016-01-18       Impact factor: 42.937

3.  Depression, hippocampal volume changes, and cognitive decline in a clinical sample of older depressed outpatients and non-depressed controls.

Authors:  Kathryn Sawyer; Elizabeth Corsentino; Natalie Sachs-Ericsson; David C Steffens
Journal:  Aging Ment Health       Date:  2012       Impact factor: 3.658

4.  Rates of depression in individuals with pathologic but not clinical Alzheimer disease are lower than those in individuals without the disease: findings from the Baltimore Longitudinal Study on Aging (BLSA).

Authors:  Melissa D Morgan; Michelle M Mielke; Richard O'Brien; Juan C Troncoso; Alan B Zonderman; Constantine G Lyketsos
Journal:  Alzheimer Dis Assoc Disord       Date:  2007 Jul-Sep       Impact factor: 2.703

Review 5.  Course and outcomes of depression in the elderly.

Authors:  Robert Kohn; Gary Epstein-Lubow
Journal:  Curr Psychiatry Rep       Date:  2006-02       Impact factor: 5.285

Review 6.  Anxiety and depression in Alzheimer's disease: a systematic review of pathogenetic mechanisms and relation to cognitive decline.

Authors:  Rossana Botto; Nicoletta Callai; Aurora Cermelli; Lorenzo Causarano; Innocenzo Rainero
Journal:  Neurol Sci       Date:  2022-04-23       Impact factor: 3.830

7.  Vortioxetine Treatment for Depression in Alzheimer's Disease: A Randomized, Double-blind, Placebo-controlled Study.

Authors:  Hye Won Jeong; Kyung Hee Yoon; Chang Hyun Lee; Yoo Sun Moon; Do Hoon Kim
Journal:  Clin Psychopharmacol Neurosci       Date:  2022-05-31       Impact factor: 3.731

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.